日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2016/08/17 | 5,340 | 5,340 | 5,080 | 5,120 | -260 | -4.8% | 186,600 |
| 2016/08/16 | 5,340 | 5,420 | 5,280 | 5,380 | +60 | +1.1% | 171,800 |
| 2016/08/15 | 5,410 | 5,470 | 5,310 | 5,320 | -160 | -2.9% | 123,200 |
| 2016/08/12 | 5,490 | 5,550 | 5,450 | 5,480 | +60 | +1.1% | 142,300 |
| 2016/08/10 | 5,340 | 5,480 | 5,330 | 5,420 | +100 | +1.9% | 148,500 |
| 2016/08/09 | 5,240 | 5,330 | 5,090 | 5,320 | +350 | +7% | 312,600 |
| 2016/08/08 | 5,000 | 5,030 | 4,890 | 4,970 | +30 | +0.6% | 231,200 |
| 2016/08/05 | 5,060 | 5,120 | 4,865 | 4,940 | -270 | -5.2% | 383,700 |
| 2016/08/04 | 5,430 | 5,450 | 5,130 | 5,210 | -270 | -4.9% | 253,400 |
| 2016/08/03 | 5,510 | 5,550 | 5,420 | 5,480 | -130 | -2.3% | 143,700 |
| 2016/08/02 | 5,600 | 5,640 | 5,580 | 5,610 | -80 | -1.4% | 77,400 |
| 2016/08/01 | 5,640 | 5,760 | 5,600 | 5,690 | +30 | +0.5% | 155,500 |
| 2016/07/29 | 5,530 | 5,670 | 5,470 | 5,660 | +150 | +2.7% | 191,300 |
| 2016/07/28 | 5,580 | 5,640 | 5,470 | 5,510 | -110 | -2% | 96,100 |
| 2016/07/27 | 5,740 | 5,780 | 5,580 | 5,620 | -70 | -1.2% | 157,400 |
| 2016/07/26 | 5,720 | 5,810 | 5,660 | 5,690 | -50 | -0.9% | 164,700 |
| 2016/07/25 | 5,740 | 5,940 | 5,720 | 5,740 | +110 | +2% | 251,700 |
| 2016/07/22 | 5,500 | 5,640 | 5,460 | 5,630 | +200 | +3.7% | 373,200 |
| 2016/07/21 | 5,430 | 5,480 | 5,360 | 5,430 | +80 | +1.5% | 451,200 |
| 2016/07/20 | 5,300 | 5,390 | 5,210 | 5,350 | +50 | +0.9% | 201,200 |
| 2016/07/19 | 5,170 | 5,300 | 5,090 | 5,300 | +90 | +1.7% | 302,300 |
| 2016/07/15 | 5,420 | 5,450 | 5,190 | 5,210 | -120 | -2.3% | 247,300 |
| 2016/07/14 | 5,240 | 5,380 | 5,230 | 5,330 | +80 | +1.5% | 192,100 |
| 2016/07/13 | 5,400 | 5,430 | 5,210 | 5,250 | -130 | -2.4% | 296,200 |
| 2016/07/12 | 5,420 | 5,470 | 5,350 | 5,380 | -60 | -1.1% | 175,900 |
| 2016/07/11 | 5,340 | 5,520 | 5,340 | 5,440 | +120 | +2.3% | 104,800 |
| 2016/07/08 | 5,440 | 5,470 | 5,310 | 5,320 | -90 | -1.7% | 95,200 |
| 2016/07/07 | 5,500 | 5,500 | 5,300 | 5,410 | -120 | -2.2% | 224,900 |
| 2016/07/06 | 5,450 | 5,550 | 5,420 | 5,530 | +40 | +0.7% | 153,000 |
| 2016/07/05 | 5,580 | 5,590 | 5,480 | 5,490 | -140 | -2.5% | 136,500 |
| 2016/07/04 | 5,550 | 5,660 | 5,500 | 5,630 | +30 | +0.5% | 169,000 |
| 2016/07/01 | 5,450 | 5,630 | 5,400 | 5,600 | +240 | +4.5% | 240,000 |
| 2016/06/30 | 5,400 | 5,430 | 5,300 | 5,360 | +70 | +1.3% | 246,500 |
| 2016/06/29 | 5,350 | 5,360 | 5,220 | 5,290 | +70 | +1.3% | 217,400 |
| 2016/06/28 | 5,170 | 5,300 | 5,150 | 5,220 | -100 | -1.9% | 350,200 |
| 2016/06/27 | 5,150 | 5,400 | 5,130 | 5,320 | +220 | +4.3% | 263,400 |
| 2016/06/24 | 5,340 | 5,420 | 5,040 | 5,100 | -190 | -3.6% | 339,400 |
| 2016/06/23 | 5,380 | 5,400 | 5,230 | 5,290 | -110 | -2% | 304,400 |
| 2016/06/22 | 5,380 | 5,460 | 5,290 | 5,400 | -10 | -0.2% | 267,100 |
| 2016/06/21 | 5,300 | 5,490 | 5,190 | 5,410 | +70 | +1.3% | 417,400 |
| 2016/06/20 | 5,440 | 5,440 | 5,310 | 5,340 | -40 | -0.7% | 412,900 |
| 2016/06/17 | 5,480 | 5,500 | 5,380 | 5,380 | -90 | -1.6% | 378,600 |
| 2016/06/16 | 5,650 | 5,690 | 5,460 | 5,470 | -210 | -3.7% | 157,300 |
| 2016/06/15 | 5,570 | 5,710 | 5,560 | 5,680 | +10 | +0.2% | 193,900 |
| 2016/06/14 | 5,700 | 5,730 | 5,580 | 5,670 | -80 | -1.4% | 189,200 |
| 2016/06/13 | 5,790 | 5,830 | 5,700 | 5,750 | -160 | -2.7% | 165,600 |
| 2016/06/10 | 5,840 | 5,910 | 5,800 | 5,910 | -30 | -0.5% | 233,600 |
| 2016/06/09 | 5,890 | 5,960 | 5,870 | 5,940 | +10 | +0.2% | 99,500 |
| 2016/06/08 | 5,840 | 5,930 | 5,810 | 5,930 | +40 | +0.7% | 193,900 |
| 2016/06/07 | 5,800 | 5,910 | 5,760 | 5,890 | +80 | +1.4% | 198,900 |
2151～
2200
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
